BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health an… Read more
Market Cap & Net Worth: BioHarvest Sciences Inc. Common Stock (BHST)
BioHarvest Sciences Inc. Common Stock (OTCQB:BHST) has a market capitalization of $130.11 Million ($130.11 Million) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #18435 globally and #6870 in its home market, demonstrating a -14.96% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BioHarvest Sciences Inc. Common Stock's stock price $5.74 by its total outstanding shares 22666842 (22.67 Million).
BioHarvest Sciences Inc. Common Stock Market Cap History: 2024 to 2025
BioHarvest Sciences Inc. Common Stock's market capitalization history from 2024 to 2025. Data shows growth from $139.40 Million to $130.11 Million (0.00% CAGR).
BioHarvest Sciences Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BioHarvest Sciences Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
5.53x
BioHarvest Sciences Inc. Common Stock's market cap is 5.53 times its annual revenue
0.14x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $139.40 Million | $25.19 Million | -$12.91 Million | 5.53x | N/A |
Competitor Companies of BHST by Market Capitalization
Companies near BioHarvest Sciences Inc. Common Stock in the global market cap rankings as of March 18, 2026.
Key companies related to BioHarvest Sciences Inc. Common Stock by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #55 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #68 globally with a market cap of $226.90 Billion USD ( CHF207.77 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #437 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #458 globally with a market cap of $47.46 Billion USD ( €46.23 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #55 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #68 | Nestlé S.A. | SW:NESN | $226.90 Billion | CHF80.84 |
| #437 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #458 | Danone SA | PA:BN | $47.46 Billion | €73.12 |
BioHarvest Sciences Inc. Common Stock Historical Marketcap From 2024 to 2025
Between 2024 and today, BioHarvest Sciences Inc. Common Stock's market cap moved from $139.40 Million to $ 130.11 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $130.11 Million | -6.67% |
| 2024 | $139.40 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of BioHarvest Sciences Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $130.11 Million USD |
| MoneyControl | $130.11 Million USD |
| MarketWatch | $130.11 Million USD |
| marketcap.company | $130.11 Million USD |
| Reuters | $130.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.